ONAPRISTONE EXTENDED-RELEASE COMPOSITIONS AND METHODS
    1.
    发明公开
    ONAPRISTONE EXTENDED-RELEASE COMPOSITIONS AND METHODS 审中-公开
    ONAPRISTONE扩展释放组合物和方法

    公开(公告)号:EP3247362A1

    公开(公告)日:2017-11-29

    申请号:EP15861014.7

    申请日:2015-11-16

    IPC分类号: A61K31/56

    CPC分类号: A61K9/20 A61K31/575

    摘要: Onapristone extended-release formulations and methods of administering onapristone extended-release formulations are provided. Onapristone extended-release formulations provide sufficient therapeutic activity as compared to immediate-release formulations with reduced potential for adverse side effects. Aspects described herein provide extended-release pharmaceutical compositions comprising onapristone as the active ingredient in an amount from about 2 mg to about 100 mg. The extended-release pharmaceutical compositions (also referred to herein as ER formulations) further comprise excipients suitable for the desired dosage form (e.g., tablet, capsule, etc.) and for delaying the release of the active ingredient.